Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses

Kirsten K Ness, Melissa M Hudson, Ching-Hon Pui, Daniel M Green, Kevin R Krull, Tseng T Huang, Leslie L Robison, E Brannon Morris, Kirsten K Ness, Melissa M Hudson, Ching-Hon Pui, Daniel M Green, Kevin R Krull, Tseng T Huang, Leslie L Robison, E Brannon Morris

Abstract

Background: Treatment regimens for childhood acute lymphoblastic leukemia (ALL) contain neurotoxic agents that may interfere with neuromuscular health. In this study, the authors examined associations between neuromuscular impairments and physical function and between neuromuscular impairments and doses of vincristine and intrathecal methotrexate used to treat leukemia among survivors of childhood ALL.

Methods: ALL survivors >10 years from diagnosis participated in neuromuscular performance testing. Treatment data were abstracted from medical records. Regression models were used to evaluate associations between treatment factors, neuromuscular impairments, and physical performance.

Results: Among 415 survivors (median age, 35 years; age range, 21-52 years), balance, mobility, and 6-minute walk (6MW) distances were 1.3 standard deviations below age-specific and sex-specific values in 15.4%, 3.6%, and 46.5% of participants, respectively. Impairments included absent Achilles tendon reflexes (39.5%), active dorsiflexion range of motion (ROM) <5 degrees (33.5%), and impaired knee extension strength (30.1%). In adjusted models (including cranial radiation), survivors who received cumulative intrathecal methotrexate doses ≥215 mg/m(2) were 3.4 times more likely (95% confidence interval, 1.2-9.8 times more likely) to have impaired ROM than survivors who received no intrathecal methotrexate, and survivors who received cumulative vincristine doses ≥39 mg/m(2) were 1.5 times more likely (95% CI, 1.0-2.5 times more likely) to have impaired ROM than survivors who received lower cumulative doses of vincristine. Higher intrathecal methotrexate doses were associated with reduced knee extension strength and 6MW distances.

Conclusions: Neuromuscular impairments were prevalent in childhood ALL survivors and interfered with physical performance. Higher cumulative doses of vincristine and/or intrathecal methotrexate were associated with long-term neuromuscular impairments, which have implications on future function as these survivors age.

Copyright © 2011 American Cancer Society.

Figures

Figure 1
Figure 1
Consort diagram
Figure 2
Figure 2
Percentages of participants with neuromuscular impairments and physical performance limitations

References

    1. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730–2741.
    1. Krishnan S, Wade R, Moorman AV, et al. Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985–2001. Leukemia. 2010;24:450–459.
    1. Kaatsch P, Reinisch I, Spix C, et al. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany. Cancer Causes Control. 2009;20:965–980.
    1. Kadan-Lottick NS, Brouwers P, Breiger D, et al. A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia. Blood. 2009;114:1746–1752.
    1. Kadan-Lottick NS, Brouwers P, Breiger D, et al. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia. J Clin Oncol. 2009;27:5986–5992.
    1. Sioka C, Kyritsis AP. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol. 2009;63:761–767.
    1. Reinders-Messelink HA, Van Weerden TW, Fock JM, et al. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia. Eur J Paediatr Neurol. 2000;4:225–233.
    1. Kumar N, Sandroni P, Steensma DP, Luthra HS, Habermann TM. Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorder. Neurology. 2008;71:1644–1645.
    1. Legha SS. Vincristine neurotoxicity. Pathophysiology and management. Med Toxicol. 1986;1:421–427.
    1. Harila-Saari AH, Huuskonen UE, Tolonen U, Vainionpaa LK, Lanning BM. Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials. Med Pediatr Oncol. 2001;36:345–351.
    1. Wright MJ, Halton JM, Barr RD. Limitation of ankle range of motion in survivors of acute lymphoblastic leukemia: a cross-sectional study. Med Pediatr Oncol. 1999;32:279–282.
    1. Harila-Saari AH, Vainionpaa LK, Kovala TT, Tolonen EU, Lanning BM. Nerve lesions after therapy for childhood acute lymphoblastic leukemia. Cancer. 1998;82:200–207.
    1. Lehtinen SS, Huuskonen UE, Harila-Saari AH, Tolonen U, Vainionpaa LK, Lanning BM. Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia. Cancer. 2002;94:2466–2473.
    1. Ramchandren S, Leonard M, Mody RJ, et al. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst. 2009;14:184–189.
    1. Gilchrist LS, Tanner L, Hooke MC. Measuring chemotherapy-induced peripheral neuropathy in children: development of the Ped-mTNS and pilot study results. Rehabilitation Oncology. 2009;27:3–15.
    1. Hartman A, van den Bos C, Stijnen T, Pieters R. Decrease in peripheral muscle strength and ankle dorsiflexion as long-term side effects of treatment for childhood cancer. Pediatr Blood Cancer. 2008;50:833–837.
    1. Vainionpaa L. Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment. Eur J Pediatr. 1993;152:115–119.
    1. Hartman A, van den Bos C, Stijnen T, Pieters R. Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine. Cancer. 2006;106:1395–1401.
    1. Hudson MM, Ness KK, Nolan VG, et al. Prospective medical assessment of adults surviving childhood cancer: Study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort Study. Pediatric Blood & Cancer. 2011;56:825–836.
    1. Marshall GL, Little JW. Deep tendon reflexes: a study of quantitative methods. J Spinal Cord Med. 2002;25:94–99.
    1. Halar EM, Hammond MC, LaCava EC, Camann C, Ward J. Sensory perception threshold measurement: an evaluation of semiobjective testing devices. Arch Phys Med Rehabil. 1987;68:499–507.
    1. Boone DC, Azen SP, Lin CM, Spence C, Baron C, Lee L. Reliability of goniometric measurements. Phys Ther. 1978;58:1355–1390.
    1. Holmback AM, Porter MM, Downham D, Lexell J. Reliability of isokinetic ankle dorsiflexor strength measurements in healthy young men and women. Scand J Rehabil Med. 1999;31:229–239.
    1. Biodex. Isokinetic testing and data interpretation normative database. [accessed February 28, 2011];Biodex. Available from: .
    1. Cohen H, Heaton LG, Congdon SL, Jenkins HA. Changes in sensory organization test scores with age. Age Ageing. 1996;25:39–44.
    1. NeuroCom International Inc. SOT Norms. Clackamas, OR: Neurocom International Inc; 2007.
    1. Isles RC, Choy NL, Steer M, Nitz JC. Normal values of balance tests in women aged 20–80. J Am Geriatr Soc. 2004;52:1367–1372.
    1. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158:1384–1387.
    1. Allison PD. Logistic Regression Using the SAS System. Cary, NC: SAS Institute; 1999.
    1. Kleinbaum D, Kupper L, Muller K. Applied regression analysis. 2nd ed. Boston, MA: PWS-Kent Publishing Co; 1988.
    1. Nashner LM. Computerized Dynamic Posturography. In: Jacobson GP, Newman CW, Kartush JM, editors. Handbook of Balance Function Testing. Clifton Park: Thompson Delmar Learning; 1997. pp. 280–307.
    1. Mecagni C, Smith JP, Roberts KE, O'Sullivan SB. Balance and Ankle Range of Motion in Community-Dwelling Women Aged 64 to 87 Years: A Correlational Study. Physical Therapy. 2000;80:1004–1011.
    1. Fernando DJ, Masson EA, Veves A, Boulton AJ. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care. 1991;14:8–11.
    1. Barr EL, Browning C, Lord SR, Menz HB, Kendig H. Foot and leg problems are important determinants of functional status in community dwelling older people. Disabil Rehabil. 2005;27:917–923.
    1. Slemenda C, Brandt KD, Heilman DK, et al. Quadriceps weakness and osteoarthritis of the knee. Ann Intern Med. 1997;127:97–104.
    1. Ostchega Y, Dillon CF, Lindle R, Carroll M, Hurley BF. Isokinetic leg muscle strength in older americans and its relationship to a standardized walk test: data from the national health and nutrition examination survey 1999–2000. J Am Geriatr Soc. 2004;52:977–982.
    1. Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci. 2006;61:72–77.
    1. Girardi M, Konrad HR, Amin M, Hughes LF. Predicting fall risks in an elderly population: computer dynamic posturography versus electronystagmography test results. Laryngoscope. 2001;111:1528–1532.
    1. Thomas IH, Donohue JE, Ness KK, Dengel DR, Baker KS, Gurney JG. Bone mineral density in young adult survivors of acute lymphoblastic leukemia. Cancer. 2008;113:3248–3256.
    1. Rasekaba T, Lee AL, Naughton MT, Williams TJ, Holland AE. The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J. 2009;39:495–501.
    1. Wise RA, Brown CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. Copd. 2005;2:125–129.
    1. Ness KK, Armenian SH, Kadan-Lottick N, Gurney JG. Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health. Expert Rev Hematol. 2011;4:185–197.
    1. Anderson SC, Baquis GD, Jackson A, Monteleone P, Kirkwood JR. Ventral polyradiculopathy with pediatric acute lymphocytic leukemia. Muscle Nerve. 2002;25:106–110.
    1. Koh S, Nelson MD, Jr, Kovanlikaya A, Chen LS. Anterior lumbosacral radiculopathy after intrathecal methotrexate treatment. Pediatr Neurol. 1999;21:576–578.
    1. Wolfson L, Whipple R, Derby CA, Amerman P, Nashner L. Gender differences in the balance of healthy elderly as demonstrated by dynamic posturography. J Gerontol. 1994;49:M160–M167.
    1. Vereeck L, Wuyts F, Truijen S, Van de Heyning P. Clinical assessment of balance: normative data, and gender and age effects. Int J Audiol. 2008;47:67–75.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅